期刊文献+

树突状细胞调控Th17/Treg平衡在动脉粥样硬化中的作用 被引量:4

下载PDF
导出
摘要 动脉粥样硬化(AS)是一种慢性炎症性疾病,大量的免疫细胞和炎症因子参与其中。树突状细胞(DCs)作为人体内功能最强的抗原提呈细胞,是整个免疫应答的中心环节;其在刺激初始T淋巴细胞增殖、诱导初始的T细胞向各个细胞亚群的分化、调控各T淋巴细胞亚群之间的平衡等方面发挥着重要作用。本文拟对DCs在AS发生发展中的作用进行介绍和评价。
出处 《安徽医科大学学报》 CAS 北大核心 2015年第4期562-564,共3页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金项目(编号:1208085MH151 1408085MH177)
  • 相关文献

参考文献22

  • 1王俊贤,陈建英.Th17介导炎症反应在动脉粥样硬化中的作用[J].广东医学院学报,2011,29(5):549-551. 被引量:1
  • 2滕广帅,邵宗鸿.树突细胞与自身免疫性疾病关系的研究进展[J].中华医学杂志,2012,92(12):859-861. 被引量:3
  • 3Steinman R M, Cohn Z A. Identification of a novel cell type in pe- ripheral lymphoid organs of mice. I. Morphology, quantitation, tis- sue distribution [ J ]. J Exp Med, 1973,137 ( 5 ) : 1142 - 62.
  • 4Galkina E, Ley K. Immune and inflammatory mechanisms of ath- eroselerosis [ J]. Annu Rev Immunol,2009,27 ( 1 ) : 165 - 97.
  • 5Aukrust P, Otterdal K, Yndested A, et al. The complex role of T- cell-based immunity in atherosclerosis [ J ]. Curr Atheroscler Rep, 2008,10(3) :236 -43.
  • 6Bettelli E, Korn T, Kuchroo V K. Th17 :the third member of the effector T cell trilogy [ J]. Curr Opin Immunol,2007,19 (6) :652 -7.
  • 7Niessner A, Sato K, Chaikof E L, et al. Pathogen-sensing plas- macytoid dendritic ceils stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha [ J ]. Circulation, 2006,114 ( 23 ) :2482 - 9.
  • 8Ohnmacht C, Pullner A, King S B, et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T ceils and results in spontaneous fatal autoimmunity [ J ]. J Exp Med, 2009,206 ( 3 ) :549 -59.
  • 9余晓洋,王彩虹,李小峰.树突状细胞对Thl7/Treg免疫平衡调节的研究进展[J].中华微生物学和免疫学杂志,2013,33(3):227-230. 被引量:7
  • 10Xie J J, Wang J, Tang T T, et al. The Th17/Treg functional im- balance during atherogenesis in ApoE (-/-) mice [ J ]. Cytokine, 2010,49(2) :185 -93.

二级参考文献124

  • 1Shih Ling HWANG,Nancy Pei-Yee CHUNG,Jacqueline Kwai-Yi CHAN,Chen-Lung Steve LIN.Indoleamine 2,3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines[J].Cell Research,2005,15(3):167-175. 被引量:12
  • 2Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med, 2000, 342 (18) : 1350-1358.
  • 3Li MO, Wan YY, Sanjabi S, et al. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol, 2006, 24 : 99-146.
  • 4Massague J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett, 2006, 580(12): 2811-2820.
  • 5Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 2003, 113(6) : 685-700.
  • 6Bluestone J A, Abbas A K. Natural versus adaptive regulatory T cells. Nat Rev lmmunol, 2003, 3(3) : 253-257.
  • 7Luo X, Yang H, Kim IS, et al. Systemic transforming growth factor-betal gene therapy induces Foxp3 + regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobesc diabetic mice. Transplantation, 2005, 79(9) : 1091-1096.
  • 8Perruche S, Zhang P, Liu Y, et al. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med, 2008, 14 (5) : 528-535.
  • 9Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-betal controls T cell tolerance and regulates Th1-and Thl7-cell differentiation, hnmunity, 2007, 26(5): 579-591.
  • 10Tone Y, Furuuchi K, Kojima Y, et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat hnmunol, 2008, 9 (2) : 194-202.

共引文献14

同被引文献35

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部